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Classification of syncope through data analytics
Joseph Hart, Jesper Mehlsen, Christian H. Olsen, Mette Sofie Olufsen, and Pierre Gremaud
Abstract—Objective: Syncope is a sudden loss of consciousness
with loss of postural tone and spontaneous recovery; it is a
common condition, albeit one that is challenging to accurately di-
agnose. Uncertainties about the triggering mechanisms and their
underlying pathophysiology have led to various classifications
of patients exhibiting this symptom. This study presents a new
way to classify syncope types using machine learning. Method: we
hypothesize that syncope types can be characterized by analyzing
blood pressure and heart rate time series data obtained from the
head-up tilt test procedure. By optimizing classification rates, we
identify a small number of determining markers which enable
data clustering. Results: We apply the proposed method to clinical
data from 157 subjects; each subject was identified by an expert
as being either healthy or suffering from one of three conditions:
cardioinhibitory syncope, vasodepressor syncope and postural
orthostatic tachycardia. Clustering confirms the three disease
groups and identifies two distinct subgroups within the healthy
controls. Conclusion: The proposed method provides evidence
to question current syncope classifications; it also offers means
to refine them. Significance: Current syncope classifications are
not based on pathophysiology and have not led to significant
improvements in patient care. It is expected that a more faithful
classification will facilitate our understanding of the autonomic
system for healthy subjects, which is essential in analyzing
pathophysiology of the disease groups.
Index Terms—Syncope, classification, clustering, machine
learning
I. INTRODUCTION
SYNCOPE is defined as a “transient loss of consciousnessdue to transient global cerebral hypoperfusion character-
ized by rapid onset, short duration and spontaneous complete
recovery” [1]; it is a prevalent disorder which accounts for
over 1 million visits to emergency departments per year in the
US alone [2]. Cerebral hypoperfusion is usually caused by a
decrease in systolic blood pressure which, in turn, is linked
to a reduction in cardiac output and total vascular resistance;
a fall in either can cause syncope, but a combination of
both mechanisms is often present [3], [4]. Standard diagnostic
methods such as the head-up tilt (HUT) test, discussed below,
only provide information about the integrated cardiovascular
response via measurements of arterial blood pressure (BP) and
heart rate (HR).
Common types of syncope have been classified to facilitate
diagnosis and treatment [5], [6], [7], [8]. However, the current
classifications are phenomenological and the corresponding
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terminology is inconsistent [5], [8]; therapeutic approaches
based on them have generally not lead to notable improve-
ments in patients’ condition. We concentrate on three patient
groups, namely cardioinhibitory syncope, vasodepressor syn-
cope and postural tachycardia, which are discussed in the next
section.
Patients are examined after repeated episodes of lighthead-
edness and fainting. Even among patients diagnosed with
syncope, these conditions cover a wide range of diseases and
are difficult to diagnose [8]. Diagnosis is typically based on
patient symptoms along with visual analysis of simultaneous
measurements of BP and HR recorded during a postural
challenge, most commonly, HUT. For the considered patients,
the end result is a significant drop in BP with or without
changes in HR; what distinguishes the groups is how these
signals change in response to the postural challenge.
In this paper, we analyze data from subjects referred to
a large regional medical center in Copenhagen, Denmark.
These subjects present symptoms of dizziness and fainting–
primarily in the upright position–and thus are suspected of
syncope associated with autonomic dysfunction. Our central
hypotheses are that (1) syncope etiology can be determined by
analysis of BP and HR data and that (2) machine learning and
mathematical modeling can fundamentally improve diagnosis
accuracy for patients suffering from syncope associated with
autonomic dysfunction.
II. DATA AND METHODS
A. Head-up tilt test
This study analyzes data from 157 subjects who have been
exposed to a head-up tilt test to examine their ability to control
BP and HR. Data were collected between 2004 to 2015 and
involve patients admitted to Frederiksberg Hospital, Denmark,
after experiencing episodes of syncope as well as a group of
healthy control subjects. Analyzed data are from subjects with
no known heart or vascular diseases. All data are extracted
from existing patient/control records and assigned random
identifiers before analysis.
After arriving at the hospital, all subjects are instrumented
with BP and ECG sensors. BP is measured using photoplethys-
mography (Finapres Medical Systems B.V.) in the index finger
of the non-dominant hand. The hand is placed in a sling at the
level of the heart. ECG is recorded using standard precordial
leads. Continuous ECG and BP signals are sampled a rate of
1.0 kHz and saved digitally using an A/D-converter communi-
cating with a computer via LabChart 7 (ADInstruments). This
program allows extraction of HR from the ECG measurement.
After clear signals are detected, the patients rest for 10 minutes
in the supine position before being tilted head-up to an angle of
60 degrees at a speed of 15 degree/second measured by way of
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Fig. 1. Typical data from the head-up title test for four subjects: healthy control and patients suffering from cardioinhibitory syncope, vasodepressor syncope
and postural tachycardia. The redline lines denote the start and end of the tilt from supine position, up to about 60o and back to supine position. Heart
rate (beats per minute) and blood pressure (mmHg) are displayed as functions of time. The blue lines correspond to the administration of nitroglycerine, a
vasodilator.
an electronic marker. The subjects remain tilted head-up during
initial passive phase of the test. In case of a negative passive
phase, a provocative drug–nitroglycerine–is administered to
facilitate the occurrence of a vasovagal reflex. This step is
taken after around 20 minutes for the healthy controls and
after a variable amount of time for the patients from the other
groups, see Fig. 1. Patients are returned to the supine position
at the same tilt speed after a total of 30 minutes or earlier if
they present signs of syncope or presyncope.
B. Data and clinical classification
For each subject, time series measurements of HR and BP
are available over the course of the head up tilt test. Our
analysis is based on data starting at two minutes before the
tilt up and lasting until two minutes after the tilt down. The
duration of the test varies for each subject and thus so do the
lengths of the time series. We denote by pi the number of
samples taken for subject i, i = 1, . . . , 157. The time series
data for the i-th subject have the form
hi = (hi1, h
i
2, . . . , h
i
pi),
bi = (bi1, b
i
2, . . . , b
i
pi),
where h and b stand respectively for HR and BP. Each
subject has been identified by a clinician as either healthy
or suffering from cardioinhibitory syncope, vasodepressor
syncope or postural orthostatic tachycardia (POTS), see Fig. 1
and text below. The corresponding distribution of subjects is
given in Table I. When administered, nitroglycerine was given
sublingually at a dose of 0.4 mg; it was given to 94% of
the healthy controls and to, respectively, 64%, 78% and 0%
of the cardioinhibitory syncope, vasodepressor syncope and
POTS patients.
class subjects age range age mean/median % female
healthy 89 14–92 50/49 67
cardio. syn. 28 15–80 33/31 63
vasodep. syn. 27 67–91 58/63 67
POTS 13 16–38 24/22 85
TABLE I
SUMMARY OF SUBJECT DISTRIBUTION.
Cardioinhibitory syncope results from excessive pooling
of blood in the lower extremities. In response, the Bezold
Jarish reflex stimulates the vagal nerve decreasing HR, and
subsequently BP, leading to syncope. Subjects in this group
experience only a few and if any pre-syncope symptoms.
Vasodepressor syncope also leads to fainting due to excessive
pooling of blood in the extremities. This condition has a
longer time scale for the fall in BP allowing prominent pre-
syncopal symptoms. For these patients, the Bezold Jarish reflex
likely inhibits sympathetic vasoconstriction thus resulting in a
significant drop in BP, which may or may not be followed by
a drop in HR, eventually inducing syncope. Finally, patients
experiencing POTS may have a reduced central blood volume
causing BP regulation to be challenged by changes in intratho-
racic pressure due to respiration. This causes pathological
fluctuations in BP with phase-shifted changes in HR elicited
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Fig. 2. Marker parameterization: the red lines represent tilt up and tilt
down times, separated by an elapsed time of T ; that interval is split into
three subintervals [0, x1T ], [x1T, x2T ] and [x2, T ], see green lines. Each
subinterval contains zi nodes, i = 1, 2, 3. The nodes (sample times) are
illustrated by the red circles. Optimal numerical values of these parameters
are given Table II.
by the baroreceptor control system. In particular, the patients
in this group have excessive vagal withdrawal leading to
inappropriate increases in HR, which further reduces cardiac
filling due to a shortening of the diastolic filling time. As
a result, HR increases while BP oscillates [9]. In addition
to these three patient groups, we analyze data from a large
group of healthy controls. These subjects were admitted as
described above but had a normal outcome during testing
of the autonomic nervous system. Diagnosis of patients was
done by one of the coauthors (Mehlsen) based on data from
the test analyzed here, on spontaneous HR variability, and on
knowledge of general symptoms and signs displayed (not used
in this study).
The classification corresponding to the above expert diag-
nosis is denoted Y i, i = 1, . . . , 157, where, for any subject,
Y takes values in the four classes introduced in the previous
paragraph. The complete data is thus
{hi, bi, Y i}157i=1.
The time series are first subsampled at 20Hz, down from
1000Hz in the original signal. Second, the signals are prepro-
cessed through a moving average window with a width of 1000
points (or equivalently 50 seconds). Finally, we normalize each
signal by subtracting its global mean for each subject. We
denote the preprocessed normalized time series by Hi and Bi
where
(Hi,Bi) ∈ RNi × RNi , i = 1, . . . , 157,
with N i referring to the number of retained sample values for
the i-th subject.
C. Random Forest classifier
A Random Forest [10] [11] is an ensemble of classification
trees [12]; this method has proven to be successful in a variety
of fields [13], [14], [15]. We use its implementation in the R
RANDOMFOREST function. To avoid overfitting and improve
model performance, the models are learned not on the full
dataset (Hi,Bi)157i=1 but on a lower dimensional set of features
(or makers) extracted from the data. We show below that high
classification rates can be obtained by restricting these markers
to simple time sampling of both the normalized HR and BP
signals (Hi,Bi)157i=1.
For each subject, one marker is placed one minute before
the tilt up and an other one minute after the tilt down.
We parameterize the placement of the remaining markers
by partitioning the “tilt up to tilt down interval” into three
subintervals
[0, x1Ti], [x1Ti, x2Ti] and [x2Ti, Ti],
where 0 < x1 < x2 < 1 and Ti denotes the elapsed
time between tilts for the i-th subject. Further, we consider
as potential markers zj points uniformly spaced in the j-
th subinterval, j = 1, 2, 3. For each interval, we retain the
sampled values which are the closest in time to
interval 1: Tup + ` x1z1−1T , ` = 0, . . . , z1 − 1,
interval 2: Tup + (x1 + ` x2−x1z2 )T , ` = 1, . . . , z2,
interval 3: Tup + (x2 + ` 1−x2z3 )T , ` = 1, . . . , z3,
with the additional conventions that if z1 = 0, there is no
node in the first interval and if z1 = 1, the first interval only
contains the node corresponding to the tilt up time, Tup. This
parameterization is illustrated in Fig. 2.
Cardioinhibitory
Healthy
Vasodepressor
POTS
Fig. 3. Barycentric coordinate representation of the classification of four
classes. Misclassified subjects are denoted by a 4. The classification is 96%
successful. Point tightness indicates how well-defined a specific class is.
We seek an optimal sampling strategy whereby, within a
predefined range, the relative sizes of the intervals defined
by x1 and x2 and the number of points z1, z2 and z3 in
each of them are chosen to maximize classification rate. More
precisely, each choice of ξ = (x1, x2, z1, z2, z3) defines a
subset of the available data Dξ with
Dξ = ∪157i=1Diξ,
where Diξ is the subset of the data for the i-th subject
corresponding to ξ. We construct a cost function through 10-
fold cross validation, namely, Dξ is partitioned as follows
Dξ = ∪10k=1Dσkξ with Dσkξ = ∪i∈σkDiξ,
where the σk’s partition {1, . . . , 157}. For each ξ, we then
consider
1: for k = 1 to 10 do
2: learn random forest Ckξ on Dξ\Dσkξ
3: compute rkξ : classification success rate of Ckξ on Dσkξ
4: end for
5: F (ξ) = 110
∑10
k=1 r
k
ξ
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Fig. 4. Silhouette representations of the clustering of the population in 4 (left) and 5 (right) clusters.
The cost function F is a measure of the successful clas-
sification rate as computed through cross validation on the
Random Forest model. Note that F inherits the stochasticity
of the Random Forest model: two calls to F with the same
input parameters may lead to two different outputs. However,
the stochastic aspect is mostly negligible here as classification
rates for the same parameterization are observed to change by
less than 2% when the model is run many times. Experiments
show that 10-fold cross validation gives a good approximation
of the classification rate attained with leave-one-out cross
validation while allowing for a 20-fold speed-up.
We find the optimal markers by solving the maximization
problem
argmax
ξ
F (ξ) subject to

0 < x1 < x2 < 1,
zi integer, i = 1, 2, 3,
zi ≥ 0, i = 1, 2, 3,
12 ≤ z1 + z2 + z3 ≤ 16,
(1)
where the last constraint was chosen through trial and error;
the retained choice balances the amount of information and
the associated cost. Indeed, to maximize F , we first fix
z1, z2, z3 and consider the function mapping from (x1, x2) 7→
F (x1, x2, z1, z2, z3) as the objective function. We optimize it
using the L-BFGS-B option in the R OPTIMX function. This
is repeated for every possible combination of z1, z2, z3 satis-
fying the constraints. The initial iterate is taken as (.5, .75);
numerical convergence is reached in 10 iterations or less in
all cases. The resulting optimal parameterization is given in
Table II and is illustrated in Fig. 2.
x1 x2 z1 z2 z3
0.4999 0.9588 5 7 3
TABLE II
OPTIMAL SAMPLING PARAMETERS FOR (1): 17 NODES ARE IDENTIFIED.
We obtain a total of 17 nodes (with one pre-tilt and
one post-tilt nodes) which correspond to 34 markers, 17 BP
values and 17 HR values. Most of the critical information is
concentrated immediately before the tilt down time. However,
many other parameterizations also attain high success rates.
Using the optimal classification rates corresponding to each
choice of z1, z2, z3 yields 605 parameterizations with mean
93%, median 94%, min 69% and max 97%. We conclude that
the classification rate is not sensitive to perturbations in the
parameterization.
D. Clustering
We cluster the subjects of the study through K-medoids [16]
[17], a centroid based clustering algorithm. For that purpose,
we use the R implementation PAM of K-medoids together with
the markers obtained in Section II.C.
The relative importance of these markers can be estimated
by permuting out-of-bag data in the Random Forest classifi-
cation model [18]. We denote by I the 34-vector of variable
importance for these markers. These relative importances are
in turn used to emphasize differences in important variables
and facilitate a meaningful clustering process. Specifically,
dissimilarities are measured through the matrix D with entries
Di,j =
√√√√ 34∑
k=1
wk(mi,k −mj,k)2, i, j = 1, . . . , 157, (2)
where mi,k is the value of the k-th marker for the i-th subject
and the weight is given by
wk =
Ik∑34
`=1 I`
.
III. RESULTS
The Random Forest model determines its classifications
according to a majority vote from 500 classification trees. We
consider the proportion of votes as a measure of confidence
the model has in its classification. Using the optimal sampling
strategy from Table II with leave-one-out cross validation we
obtain a classification rate of 96%. Fig. 3 shows the patients
plotted using the barycentric coordinates of the proportion of
votes. The color legend identifies the classification from expert
clinicians.
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Fig. 5. Normalized BP and HR evolution for the two healthy clusters (green and magenta) from Fig. 4, right, and the POTS subjects (black); normalized
signals are obtained by subtracting the individual global temporal mean from the original signal. Left: BP; the healthy subjects demonstrate two different
behaviors; right: HR; the healthy subjects display the same behavior.
Clustering under the assumption of four distinct clusters
leads to the spreading the healthy subjects into two classes,
one with essentially only healthy subjects and the other with
a mixture of the rest of the healthy population with the POTS
patients. Fig. 4, left, displays the Silhouette representation [19]
corresponding to this clustering. Silhouette values greater than
0 indicate that the patient fits best in its cluster; values less
than 0 indicate that it fits better in another cluster. Interestingly,
clustering into five groups leads to a surprising results as two
different groups of healthy subjects emerge, see Fig. 4, right,
while the other three groups, i..e, cardioinhibitory syncope,
vasodepressor syncope and POTS, all form their own cluster.
We also note that, in agreement with the classification results,
see again Fig 3, the vasodepressor group appears to be the
most challenging to characterize.
Further investigation reveals that there is indeed a distinction
between the two identified “healthy” clusters. This can be seen
by computing, across clusters, an average BP at each sample
point. The resulting averages are then plotted at each marker,
i.e., at a collection in increasing times. In other words, the
horizontal axis is a pseudo-time (i.e., a nonlinear time scale).
Fig. 5 displays these results for the two healthy cluster of
Fig. 4, right, and the POTS cluster. There is a noticeable
difference in BP behavior among the two healthy groups; this
separated subjects who experience a drop in BP following
nitroglycerine from those who do not not. No such difference
is observed for the HR. Figure 6 illustrates data from one
subject in each of the two healthy groups.
IV. DISCUSSION AND CONCLUSION
Based on the above findings, we observe that supervised
machine learning–here in the form of Random Forests–can be
used to successfully differentiate between healthy subjects and
syncope patients; furthermore, our approach can also identify
all three types of syncope considered here (cardioinhibitory,
vasodepressor and POTS) with success rates in the high 90%
among the syncope patients. Most of the existing related
studies concentrate only on differentiating between healthy
subjects on the one hand and syncope patients on the other.
Various degrees of success are being reported [20] depending
on the type of markers/features considered (for instance time
domain based versus frequency based), the population size
(large versus small), the methods (linear versus non-linear
analysis) and the amount of information taken into account.
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Fig. 6. Difference in recorded behavior between a subject from the first group of healthy control (green line in Fig. 5) on the left and a subject from the
second group (magenta line in Fig. 5) on the right.
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These studies often consider the issue of early syncope pre-
diction where the goal is to identify subjects susceptible to
syncope as early as possible during HUT. While not directly
aimed at early prediction, the present work is however relevant
to it: the optimal marker locations discussed in Section III
clearly (and not surprisingly) emphasize the importance of
the information gathered shortly before syncope, i.e., shortly
before tilt-down, corresponding to interval 3 above. This is
confirmed by [20] where the authors fail to make clinically
useful predictions of the test outcome by concentrating on
data from the first 15mn following tilt-up (and thus mostly
“missing” that critical time). While the results in [21] are more
encouraging, the authors do make use of data in the last minute
before syncope in over half of their results.
Our focus is on the multi-class classification and clustering
of syncope data. We are not aware of similar published studies.
A possible explanation for the dearth of closely related work
might be the difficulty of defining these very classes, a task
the present study starts revisiting. Future work will involve
the classification of patients presenting not only the three
pathologies discussed above but also other types of syncope
such as dysautonomia, postural hypotension and orthostatic
intolerance, see Fig. 7.
Unlike other recent work on syncope data such as [22],
we do not retain as features quantities explicitly dependent
upon the time-frequency analysis of the two signals BP and
HR; instead, we simply sample the signals at optimized times.
Although the inclusion of “variation dependent features” did
not lead to higher classification rates, we expect that properly
chosen quantifiers based on local spectral properties are likely
to improve our analysis; this is the topic of ongoing efforts.
The main purpose of the above classification is the iden-
tification of representative markers that can then be used to
define a notion of distance (or dissimilarity) between subjects
and, ultimately, for clustering. The distance between subject
i and j is here taken as Dij in (2). The weighted 2-norm
introduced in (2) is a very natural way of combining the
various markers and their relative importance. While clustering
largely confirm the validity of the initial clinical classification,
it does uncover the existence of two distinct healthy groups.
The two healthy groups differentiate patients who are able
to maintain BP in response to nitroglycerine versus those
who experience a small BP drop, though not sufficient to
experience pre-syncope or syncope; all patients in the control
group were non-symptomatic (they did not faint). One possible
explanation is that the subgroup of healthy controls that
experience a BP drop following nitroglycerine administration
have sympathetic stimulation operating near or at its maximum
(before vasodilation induced by nitroglycerine), and therefore
were not able to maintain a high BP through vasoconstriction
in response to nitroglycerine.
Future work will involve the clustering analysis of patients
with symptoms that do not fit the pathologies considered
here. Further research is also necessary to investigate possible
pathophysiological characterizations of the above two healthy
groups. It is expected that direct mathematical modeling will
facilitate the characterization of these and other groups through
the testing of different possible scenarios and root causes.
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